Shares outstanding decreased 90.5%
Shares outstanding changed -90.5% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
76,845,904→7,264,4148 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CUE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 82099 bp lower
Operating margin changed -82099 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-292.32%→-1113.30%3 prior comparisons
Revenue increased 166.7%
Revenue changed +166.7% from the comparable as-filed period.
$3.0M→$7.9M3 prior comparisons
Cash & equivalents decreased 36.7%
Cash & equivalents changed -36.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$27.5M→$17.4M4 prior comparisons
Operating income changed across a low base
Operating income changed -915.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 3 consecutive comparable moves in the opposite direction.
-$8.6M→-$87.7M3 prior comparisons
Research & development increased 519.6%
Research & development changed +519.6% from the comparable as-filed period.
$7.9M→$49.0M3 prior comparisons
SBC / revenue moved 25987 bp higher
SBC / revenue changed +25987 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
42.76%→302.63%3 prior comparisons
Working capital decreased 53.4%
Working capital changed -53.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$11.6M→$5.4M4 prior comparisons
Net income changed across a low base
Net income changed -1704.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 3 consecutive comparable moves in the opposite direction.
-$8.5M→-$153.1M3 prior comparisons
Total assets decreased 24.6%
Total assets changed -24.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$40.7M→$30.7M4 prior comparisons
Free-cash-flow margin moved 25169 bp lower
Free-cash-flow margin changed -25169 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-116.52%→-368.21%3 prior comparisons
Operating cash-flow margin moved 25261 bp lower
Operating cash-flow margin changed -25261 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-115.61%→-368.21%3 prior comparisons
R&D / revenue moved 35438 bp higher
R&D / revenue changed +35438 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
267.77%→622.15%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.